Crouse Health Online: Wellness is just a click away.
Share Share
  |  Connect with Us: 
Text Size

Health News

Cancer Patients at Risk for Serious Blood Clots: Study

Cancer Patients at Risk for Serious Blood Clots: Study


FRIDAY, Sept. 30 (HealthDay News) -- Blood clots affect as many as one in five U.S. cancer patients and sharply increase the cost of their care, a new study has found.

Researchers analyzed data from 30,552 cancer patients in the United States and found a large number developed a potentially deadly blood clot called a venous thromboembolism (VTE) within a year of undergoing chemotherapy for certain types of cancers.

One year after treatment, VTE occurred in 21.5 percent of pancreatic cancer patients, 16.7 percent of stomach cancer patients, 14.8 percent of lung cancer patients, 11.9 percent of colorectal cancer patients, 11.4 percent of ovarian cancer patients and 9.9 percent of bladder cancer patients, the investigators found.

It's not fully understood why VTEs can develop during cancer treatment, but contributing factors include chemotherapy side effects, blood-clotting agents released by tumors, and pre-existing health issues such as obesity and anemia, according to researchers led by Dr. Gary H. Lyman, a professor of medicine at Duke Cancer Institute.

The average cost of care for a cancer patient who develops a VTE and requires medication and hospitalization is $110,362, compared with $77,984 for a patient who does not have a VTE.

"Direct medical costs of health care are significantly greater among cancer patients experiencing a VTE and still do not include caregiver expenses, out-of-pocket costs and the intangible costs of pain and suffering," Lyman said in a Duke news release.

The ability to identify patients with the highest risk of developing blood clots could improve preventive use of anti-clotting medicine or blood thinners, Lyman suggested.

The study, which is slated for presentation Monday at the European Multidisciplinary Cancer Congress in Stockholm, was supported by the pharmaceutical company Sanofi.

Experts note that study findings presented at medical meetings should be viewed as preliminary until published in a peer-reviewed journal.

More information

The American Society of Clinical Oncology has more about cancer patients and blood clots.

Copyright © 2011 HealthDay. All rights reserved.

Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.


Latest News

Crouse Hospital Appoints Chief Information Officer
more >

MedEx Bedside Prescription Delivery Service

Free service offers convenience, patient education at discharge.
more >

Weight Loss Surgery

Is it right for you? Attend a free information seminar held twice monthly.
more >

Quality at Crouse

See how Crouse Hospital strives to provide the best in patient care.
more >

Cheer Up That Special Someone

Say get well or welcome a new arrival with a gift purchased right at Crouse.

more >

Make an Online Donation Now

Your donation of any amount helps support Crouse services & programs in a meaningful way.
more >

Shop Online Now

Say get well, thinking of you or welcome new baby with a unique gift from the Crouse Gift Shop.

more >